TransMedics Group, Inc. has grown revenue 64% a year over three years and 86% a year over five. Revenue growth, 3-year annual rate: +64% (Medical Devices median +12%). Revenue growth, 5-year rate: +86%, growth has slowed since the five-year average. Years of annual history on file: 9, FY2017 to FY2025, as filed.

TMDXTransMedics Group, Inc.

Healthcare

$77.81-36% 1Y

$77.81

$62.0452 weeks$150.42

Is it growing?

Good

Growing: revenue growing +26% year on year and earnings up +99% year on year.

2 good, 1 neutral

Revenue trend+26% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +86% a year.

Earnings trend+99% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing faster than revenue, so margins or the share count are helping.

Margin direction−0.9 points operating

Trailing-twelve-month operating margin, 12.4% now against 13.3% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Revenue growth, 3 yearstop 1% of the market

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is TMDX growing?

TransMedics Group, Inc. has grown revenue 64% a year over three years and 86% a year over five.

+64%

Revenue growth, 3-year annual rate · Medical Devices median +12% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +86%
Revenue growth, 5-year rate · +64% over three · growth has slowed since the five-year average
Years of annual history on file: 9
Years of annual history on file · FY2017 to FY2025, as filed

Details›